Detroit Medical Center at IDWeek 2026

Oct 21–24, 2026 Washington, DC ~12k attendees Website

Detroit Medical Center brings 2 presentations to IDWeek 2026 in Washington. Its program focuses on resistant gram-negative bloodstream infections and how to treat them. One study tracks a shift from KPC dominance to NDM parity among carbapenemases in a safety-net health system, and another compares ceftriaxone with AmpC-stable beta-lactams for low-risk AmpC-producing Enterobacterales bacteremia.

OrganizationIDWeek 2026 Attendance
Poster
Thu Oct 22
12:15pm–1:30pm
Ceftriaxone Versus AmpC-Stable β-Lactams for Low-Risk AmpC-Producing Enterobacterales Bacteremia
Poster Hall B-C · Poster P-112
A4. Treatment of antimicrobial resistant infections
Poster
Thu Oct 22
12:15pm–1:30pm
From KPC Dominance to NDM Parity: Evolving Carbapenemase Epidemiology in a Detroit Safety-Net Health System, 2021–2025
Poster Hall B-C · Poster P-1422
N10. Health Care-Associated Infections: Gram-negatives (MDR-GNR)

Explore the full IDWeek 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Washington. Leave your work email and we’ll be in touch.

Privacy

Download the full IDWeek 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Instantly find 20 buyers from Detroit Medical Center

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with or endorsed by IDWeek, the Infectious Diseases Society of America (IDSA) or its partner societies (SHEA, HIVMA, PIDS and SIDP). Submit a correction